(Q36839937)

16 August 2017

1 reference

title

Dyslipidemia in type 2 diabetes mellitus (English)

1 reference

16 August 2017

1 reference

1 reference

Ramprasad Gadi

1

1 reference

16 August 2017

Frederick F Samaha

series ordinal

2

1 reference

16 August 2017

publication date

1 June 2007

1 reference

16 August 2017

published in

Current diabetes report

1 reference

16 August 2017

volume

7

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

228-234

1 reference

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-007-0036-0

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-007-0036-0

Mechanistic studies on metabolic interactions between gemfibrozil and statins

21 January 2018

1 reference

12 December 2020

Metformin: effects on cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

1 reference

12 December 2020

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial

1 reference

12 December 2020

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors

1 reference

12 December 2020

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Standards of medical care in diabetes--2006

1 reference

12 December 2020

Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Management of dyslipidemia in NIDDM.

1 reference

12 December 2020

Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Niacin as a component of combination therapy for dyslipidemia

1 reference

12 December 2020

Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities

1 reference

12 December 2020

The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states

1 reference

12 December 2020

Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.

1 reference

12 December 2020

Hypertriglyceridemia: a contraindication to the use of bile acid binding resins

1 reference

12 December 2020

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

10.1007/S11892-007-0036-0

Identifiers

DOI

1 reference

16 August 2017

1 reference